Neurotransmitters, neurosteroids and neurotrophins: new models of the pathophysiology and treatment of depression.
Wolkowitz
Owen M
OM
Reus
Victor I
VI
D000928:Antidepressive Agents / Q000627:therapeutic use*; D003346:Corticotropin-Releasing Hormone / Q000502:physiology; D003687:Dehydroepiandrosterone / Q000502:physiology*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology*; D004298:Dopamine / Q000502:physiology*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000502:physiology*; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D008032:Limbic System / Q000503:physiopathology; D008297:Male; D009414:Nerve Growth Factors / Q000502:physiology*; D010913:Pituitary-Adrenal System / Q000503:physiopathology; D012701:Serotonin / Q000502:physiology*
D000928:Antidepressive Agents; D009414:Nerve Growth Factors; D012701:Serotonin; D003687:Dehydroepiandrosterone; D003346:Corticotropin-Releasing Hormone; D004298:Dopamine; D006854:Hydrocortisone